The Journal of Pain
Volume 10, Issue 9 , Pages 976-983 , September 2009

Comparison of Health Care Use and Costs in Newly Diagnosed and Established Patients With Fibromyalgia

  • Leigh Ann White

      Affiliations

    • Analysis Group, Inc, Boston, Massachusetts
    • ,
  • Rebecca L. Robinson

      Affiliations

    • Eli Lilly and Company, Indianapolis, Indiana
    • Corresponding Author InformationAddress reprint requests to Ms Rebecca L. Robinson, Eli Lily and Co, Lilly Research Labs, Lilly Corporate Center, Indianapolis, IN 46259.
    • ,
  • Andrew P. Yu

      Affiliations

    • Analysis Group, Inc, Boston, Massachusetts
    • ,
  • Anna Kaltenboeck

      Affiliations

    • Analysis Group, Inc, Boston, Massachusetts
    • ,
  • Seth Samuels

      Affiliations

    • Analysis Group, Inc, Boston, Massachusetts
    • ,
  • David Mallett

      Affiliations

    • Ingenix, Inc, Rocky Hill, Connecticut
    • ,
  • Howard G. Birnbaum

      Affiliations

    • Analysis Group, Inc, Boston, Massachusetts

Received 6 October 2008 ,Revised 19 February 2009 ,Accepted 18 March 2009.

References 

  1. Annemans L, Wessely S, Spaepan E, Caekelbergh K, Caubère JP, Le Lay K, et al. Health economic consequences related to the diagnosis of fibromyalgia syndrome. Arthritis Rheum. 2008;58:895–902
  2. Arnold LM. New therapies in fibromyalgia. Arthritis Res Ther. 2006;8:212–232
  3. Berger A, Dukes E, Martin S, Edelsberg J, Oster G. Characteristics and healthcare costs of patients with fibromyalgia syndrome. Int J Clin Pract. 2007;61:1498–1508
  4. Bernard AL, Prince A, Edsall P. Quality of life issues for fibromyalgia patients. Arthritis Care Res. 2000;13:42–50
  5. Birnbaum HG, White AG, Reynolds JL, Greenberg PE, Zhang M, Vallow S, et al. Estimated costs of prescription opioid analgesic abuse in the US in 2001: A societal perspective. Clin J Pain. 2006;22:667–676
  6. Burckhardt CS, Goldenberg D, Crofford L, Gerwin R, Gowens S, Jackson K, et al. Guideline for the management of fibromyalgia syndrome pain in adults and children. Glenview, IL: American Pain Society; 2005;
  7. Goldenberg DL, Burckhardt C, Crofford L. Management of fibromyalgia syndrome. JAMA. 2004;292:2388–2395
  8. Goldenberg DL. Pharmacological treatment of fibromyalgia and other chronic musculoskeletal pain. Best Pract Res Clin Rheumatol. 2007;21:499–511
  9. Hughes G, Martinez C, Myon E, Taïeb C, Wessely S. The impact of a diagnosis of fibromyalgia on health care resource use by primary care patients in the UK: An observational study based on clinical practice. Arthritis Rheum. 2006;54:177–183
  10. Mease P. Fibromyalgia syndrome: Review of clinical presentation, pathogenesis, outcome measures, and treatment. J Rheumatol. 2005;32(Suppl):6–21
  11. Robinson RL, Birnbaum HG, Morley MA, Sisitsky T, Greenberg PE, Claxton AJ. Economic costs and epidemiological characteristics of patients with fibromyalgia claims. J Rheumatol. 2003;30:1318–1325
  12. Robinson RL, Jones ML. In search of pharmacoeconomic evaluations for fibromyalgia treatments: A review. Expert Opin Pharmacother. 2006;7:1027–1039
  13. White KP, Speechley M, Harth M, Ostbye T. The London Fibromyalgia Epidemiology Study: Direct health care costs of fibromyalgia syndrome in London, Canada. J Rheumatol. 1999;26:885–889
  14. White KP, Nielson WR, Harth M, Ostbye T, Speechley M. Does the label “fibromyalgia” alter health status, function, and health service utilization? A prospective, within-group comparison in a community cohort of adults with chronic widespread pain. Arthritis Rheum (Arthritis Care Res). 2002;47:260–265
  15. White LA, Birnbaum HG, Kaltenboeck A, Samuels S, Mallett D, Robinson RL. Medical care and APS guideline-related prescription drug use in newly diagnosed and established fibromyalgia patients. [abstract] J Pain. 2008;9:P16
  16. White LA, Birnbaum HG, Kaltenboeck A, Tang J, Mallett D, Robinson RL. Employees with fibromyalgia: Medical comorbidity, healthcare costs, and work loss. J Occup Environ Med. 2008;50:13–24
  17. Wolfe F, Ross K, Anderson J, Russell IJ, Herbert L. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum. 1995;38:19–28

 Supported by Eli Lilly and Company.

PII: S1526-5900(09)00470-2

doi: 10.1016/j.jpain.2009.03.012

The Journal of Pain
Volume 10, Issue 9 , Pages 976-983 , September 2009

Article Tools